[1]. Effect of Early Nutritional Support on Quality of Life by EORTC QLQ-C30 in Allogeneic Hematopoietic Stem Cell Transplantation.
Blood cell therapy [Volume]5 [Issue]4 [Page]107 -115 (2022/) [Reviewed] Yes
[DOI] [2]. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
Cancer science [Volume]113 [Issue]9 [Page]3267 -3270 (2022/) [Reviewed] Yes
[DOI] [3]. 【血液疾患における抗体医薬と免疫細胞療法の新たな展開】多発性骨髄腫に対するCAR-T細胞療法の現状と開発動向
血液内科 (有)科学評論社 [Volume]85 [Issue]1 [Page]47 -53 (2022/) [Reviewed] No
[Repository][4]. 乾癬様皮疹を呈した慢性移植片対宿主病の1例
日本皮膚科学会雑誌 (公社)日本皮膚科学会 [Volume]132 [Issue]8 [Page]1885 (2022/) [Reviewed] Yes
[5]. Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase.
Leukemia research reports [Volume]17 [Page]100312 (2022/) [Reviewed] Yes
[DOI]